← Eichor
Condition: Keratitis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Keratitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Intrastromal Moxifloxacin as an Adjunctive Therapy in Recalcitrant Bacterial Keratitis
NA · 1 location(s) · Minia University · NCT07394257Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune D
Phase 4 · 1 location(s) · Toyos Clinic · NCT06964269Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells
Phase 2 · 4 location(s) · University of Illinois at Chicago · NCT05705024Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface
Phase N/A · 2 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT04198740The Prevalence of Hypoesthesia Related Keratitis in Ocular Graft Vs. Host Disease (GVHD) Patients
Phase N/A · 1 location(s) · Indiana University · NCT04700657Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease
Phase 2 · 1 location(s) · University of Illinois at Chicago · NCT06919081Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking
Phase 1 · 1 location(s) · Pacific Clear Vision Institute · NCT03918408An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED
Phase 3 · 77 location(s) · Dompé Farmaceutici S.p.A · NCT07519902A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis
Phase 2 · 1 location(s) · Shanghai BDgene Co., Ltd. · NCT06474442Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis
Phase 2 · 1 location(s) · BRIM Biotechnology Inc. · NCT05927428Parasitic Ulcer Treatment Trial
Phase 3 · 17 location(s) · Jeremy Keenan, MD, MPH · NCT06213649Complex Ocular Infection, Optimization of Microbiological Diagnosis
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05432336Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis
EARLY_Phase 1 · 1 location(s) · Eye & ENT Hospital of Fudan University · NCT06451172Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A
Phase 3 · 2 location(s) · University of California, San Francisco · NCT06658002Real-World Assessment of VEVYE® for Short-Term Symptom and Sign Improvement of Dry Eye Disease in a Neuro-Ophthalmology
Phase N/A · 1 location(s) · Neuro-Ophthalmology of Texas · NCT07566975Non-invasive Diagnostics of Microbial Keratitis
Phase N/A · 1 location(s) · Sorlandet Hospital HF · NCT06364878Follow-up Compliance for Corneal Ulcer Patients With SMS Reminder
NA · 1 location(s) · Seva Canada Society · NCT07377513Use of a New Method for the Microbiological Diagnosis of Severe Corneal Infection
Phase N/A · 1 location(s) · CHU de Reims · NCT05888987Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
Phase 3 · 36 location(s) · ReGenTree, LLC · NCT05555589A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of
Phase 2 · 3 location(s) · TearSolutions, Inc. · NCT07568730A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis
Phase 1/Phase 2 · 9 location(s) · Krystal Biotech, Inc. · NCT06999733A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic Keratitis
Phase 2 · 1 location(s) · Staidson (Beijing) Biopharmaceuticals Co., Ltd · NCT06975748Clinical Study of Intrastromal Anti-VEGF Injection for Corneal Neovascularization.
Phase 1/Phase 2 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07329686
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.